CN1058409C - Medicine for quickly curing osteoproliferation - Google Patents
Medicine for quickly curing osteoproliferation Download PDFInfo
- Publication number
- CN1058409C CN1058409C CN96119419A CN96119419A CN1058409C CN 1058409 C CN1058409 C CN 1058409C CN 96119419 A CN96119419 A CN 96119419A CN 96119419 A CN96119419 A CN 96119419A CN 1058409 C CN1058409 C CN 1058409C
- Authority
- CN
- China
- Prior art keywords
- present
- medicine
- symptoms
- rhizoma
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 13
- 229940079593 drug Drugs 0.000 title 1
- 206010005963 Bone formation increased Diseases 0.000 claims abstract description 8
- 241000218176 Corydalis Species 0.000 claims abstract description 4
- 241000005787 Cistanche Species 0.000 claims description 3
- 241000628997 Flos Species 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- -1 electuary Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000002994 raw material Substances 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 10
- 239000008280 blood Substances 0.000 abstract description 8
- 201000010099 disease Diseases 0.000 abstract description 7
- 208000024891 symptom Diseases 0.000 abstract description 7
- 210000004369 blood Anatomy 0.000 abstract description 6
- 210000000988 bone and bone Anatomy 0.000 abstract description 6
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- 230000006870 function Effects 0.000 abstract description 3
- 208000012659 Joint disease Diseases 0.000 abstract description 2
- 230000017531 blood circulation Effects 0.000 abstract description 2
- 208000035475 disorder Diseases 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 210000003734 kidney Anatomy 0.000 abstract description 2
- 238000005728 strengthening Methods 0.000 abstract description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 206010008631 Cholera Diseases 0.000 abstract 1
- 241000336315 Cistanche salsa Species 0.000 abstract 1
- 241001494479 Pecora Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 241000913745 Spatholobus Species 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 235000012907 honey Nutrition 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000003950 pathogenic mechanism Effects 0.000 abstract 1
- 230000007850 degeneration Effects 0.000 description 4
- 108010048734 sclerotin Proteins 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 206010013754 Drug withdrawal syndrome Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010021703 Indifference Diseases 0.000 description 1
- 206010061363 Skeletal injury Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000005786 degenerative changes Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229940029329 intrinsic factor Drugs 0.000 description 1
- 230000008407 joint function Effects 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention belongs to a Chinese patent medicine for treating bone retrograde affection. Through clinical research for years, the pathogenic mechanisms of bone retrograde affection are held, and the clinical manifestation belongs to small joint disease or named as small joint functional disorder. The theory of the treatment of both symptoms and root causes of diseases of traditional Chinese medicine is adopted, and the present invention takes effects on 'evil repletion positive weakness'. The formula of the present invention has the functions of activating blood circulation to dissipate blood stasis, expelling wind, eliminating cold, regulating qi-flowing for relieving pain, invigorating the kidney, strengthening the bones for generating pith and inhibiting hyperosteogeny. The formula comprises cholera of sheep, rhizoma cibotii, prepared rhizome of rehmannia, rhizoma drynariae, cistanche salsa, suberect spatholobus, safflower, corydalis tuber and sugar or honey as assistance. The effective rate of the present invention is 95.4%, and the cure rate is 87.2%. Common symptoms can be cured for 20 days, serious symptoms can be obviously lightened, and the present invention can prevent the states of illness from relapsing.
Description
The invention belongs to the Chinese patent medicine of treatment sclerotin degeneration, particularly a kind ofly can cure hyperosteogeny in a short time, a kind of medicine for the treatment of hyperosteogeny that does not recur.
Hyperosteogeny disease (sclerotin degeneration) is one of Orthopeadic Surgery commonly encountered diseases frequently-occurring disease, and it is perplexing the healthy of numerous middle-aged and elderly people, even makes it disability, causes lifelong misery.The treatment of this disease is paced up and down at balky state always, becomes a difficult problem of not separating, and it is following four kinds that present Therapeutic Method does not have outer: the firstth, and relatively Chang Yong oral medicine such as bony spur tablet, oral liquid etc.; The secondth, general externally applied liniment, external application plaster etc.; The 3rd is manipulation, as therapies such as massage, massage, the qigong; The 4th is operative treatment, but its nearly long-term effect is all not satisfactory, and above-mentioned therapy subtracts the disease therapy logical the genus, in case withdrawal symptom can occur once again.
The purpose of this invention is to provide a kind of table, this double controlling, eliminate in a short time or mitigation symptoms, restore funcitons is also regulated the whole body function by medicine, effectively controls whole body sclerotin hypertrophy once again, and a kind of medicine for the treatment of hyperosteogeny of the change of the outgrowth bone of graduation.
Through for many years to the summary of year clinical trial surplus the research and 20 of sclerotin degeneration mechanism, its clinical symptoms all belongs to the vertebral articulations disease and also claims little joint disease or little joint function disorder, mainly be meant joint of lumbar vertebra and cervical vertebra joint, latter's symptom outstanding and more after also the most bad.Cause and the interior external variation of being familiar with osteoproliferation disease with theory of Chinese medical science then belong to liver unit thanks to void, deficiency of liver-blood, the skeleton development is latent to be split, overworks slightly or wound, just cause stagnation of QI-blood and do to ache, muscles is not hard in addition, once frequent activities, wearing and tearing, then cause the too early too fast degenerative change in little joint; The 2nd,, momentary and super mobility external force or strain, acting on spinal column, can to cause that QI and blood takes place for stressed the most concentrated part disorderly contrary, heavy then cause bone injury, blood oozing from the body openings or subcuta neous tissue arteries and veins, to form blood stasis sluggish, cause the vertebral bones structural damage, lose nourishing, the skeleton degeneration that occurs of a specified duration; The 3rd, the affection of exogenous wind-cold damp its by the body intrinsic factor, deficiency of kidney-QI often congenitally loses emptyly, skeletal structure is bad, or muscles is not hard, then feels exopathogen, the circular flow of blocking solution QI and blood does not freely form pathogenic factor.
With this, emphasis is caught " domination of pathogen is weakened body resistance " in treatment: blood circulation promoting and blood stasis dispelling, expelling wind and cold, regulating QI to relieve pain, invigorating the kidney and strengthening the bones are given birth to marrow, suppress hyperosteogeny, are regulated and recover little function of joint, thereby reach therapeutic purposes.The clinical treatment of year Chinese patent medicine Cheng Fang is developed into following prescription surplus 20 in view of the above: (weight g)
Folium Epimedii 25-50 Rhizoma Cibotii 25-50 Radix Rehmanniae Preparata 25-50 Rhizoma Drynariae 15-25
Herba Cistanches 15-25 Caulis Spatholobi 15-25 Rhizoma Corydalis 10-15 Flos Carthami 25-50
Brown sugar 50-150 or an amount of Mel are made decoction, electuary, pill, powder, tablet etc.
The present invention is year clinical constantly perfect surplus 20, name surplus the treatment patient 2000 on the books, its cure rate 87.2%, effective percentage 95.4%, men and women's indifference, sick time is short, the age is little is directly proportional with effective percentage, cure rate, treats general symptom with this medicine and takes medicine and can heal entirely in 20 days, and weight person's symptom obviously alleviates and can control pathological changes no longer repeatedly.
Embodiment:
Folium Epimedii 50g, Rhizoma Cibotii 50g, Radix Rehmanniae Preparata 50g, Rhizoma Drynariae 25g Herba Cistanches 25g, Caulis Spatholobi 25g, Rhizoma Corydalis 15g, Flos Carthami 50g, above medical herbs adds decocting and becomes the 500ml decoction, is potion with brown sugar 150g, each agent clothes five days, four doses (obeying 20 days) are a course of treatment, can fully recover.
Claims (1)
1, a kind of medicine for the treatment of hyperosteogeny is characterized in that said composition is decoction, pill, electuary, powder, the tablet of being made by the following raw materials by weight proportions thing:
Folium Epimedii 25～50g Rhizoma Cibotii 25～50g Radix Rehmanniae Preparata 20～50g
Rhizoma Drynariae 15～25g Herba Cistanches 15～25g Caulis Spatholobi 15～25g
Rhizoma Corydalis 10～15g Flos Carthami 15～25g brown sugar 50～150g or an amount of Mel.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96119419A CN1058409C (en) | 1996-09-18 | 1996-09-18 | Medicine for quickly curing osteoproliferation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96119419A CN1058409C (en) | 1996-09-18 | 1996-09-18 | Medicine for quickly curing osteoproliferation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1148500A CN1148500A (en) | 1997-04-30 |
| CN1058409C true CN1058409C (en) | 2000-11-15 |
Family
ID=5125680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN96119419A Expired - Fee Related CN1058409C (en) | 1996-09-18 | 1996-09-18 | Medicine for quickly curing osteoproliferation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1058409C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110478422A (en) * | 2019-07-16 | 2019-11-22 | 山东快愈烂足中医药科技有限公司 | A kind of oral medicine and preparation method thereof for treating lumbar vertebrae cervical vertebrae hyperosteogeny and disc herniation |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107184728A (en) * | 2017-05-22 | 2017-09-22 | 漯河医学高等专科学校 | A kind of collaterals and relieving pain cream and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1087541A (en) * | 1993-09-23 | 1994-06-08 | 高学泰 | Medicine for treating lumbar vertebra hyperosteogeny |
| CN1097131A (en) * | 1993-07-07 | 1995-01-11 | 汪孝文 | Gulingdan pill |
-
1996
- 1996-09-18 CN CN96119419A patent/CN1058409C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1097131A (en) * | 1993-07-07 | 1995-01-11 | 汪孝文 | Gulingdan pill |
| CN1087541A (en) * | 1993-09-23 | 1994-06-08 | 高学泰 | Medicine for treating lumbar vertebra hyperosteogeny |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110478422A (en) * | 2019-07-16 | 2019-11-22 | 山东快愈烂足中医药科技有限公司 | A kind of oral medicine and preparation method thereof for treating lumbar vertebrae cervical vertebrae hyperosteogeny and disc herniation |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1148500A (en) | 1997-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1634225A (en) | Medicine for reducing swelling, easing pain, promoting bone reunion and the preparation process thereof | |
| CN100376276C (en) | Soothe tendons and activating-blood anodyne plaster | |
| CN101757148A (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
| CN101549137A (en) | Chinese medicine preparation for treating bone joint disease | |
| CN1170566C (en) | Externally applied pain-relieving plaster and its prepn | |
| CN1069527C (en) | Medicine for hyperosteogeny and wind-cold syndrome | |
| CN101991742A (en) | Traditional Chinese medicine formula for treating lumbar disc herniation | |
| CN101293041B (en) | Externally used medicament for treating protrusion of lumbar vertebral disc, spinal canal stenosis | |
| CN1058409C (en) | Medicine for quickly curing osteoproliferation | |
| CN101112482A (en) | Medicine for treating traumatic injury | |
| CN1234385C (en) | Health-care medicinal plaster used for preventing and curing discopathy, osteosis, ischialgia | |
| CN1112206C (en) | Bone fracture setting medicine powder | |
| CN102198246B (en) | Chinese medicinal preparation for treating bone diseases | |
| CN108815415B (en) | Externally-applied medicine for treating rheumatic ostealgia and preparation method thereof | |
| CN102526418B (en) | Drug for treating lumbar disc herniation and preparation method thereof | |
| CN101284087B (en) | Medicinal composition for curing lumbar disease | |
| CN101439136B (en) | Plaster for treating bone disease and soft tissue injury | |
| CN101417059B (en) | Ointment for treating burn and scald and preparation method thereof | |
| CN1060076C (en) | Gucixiao pill for removing spur | |
| CN100542583C (en) | A kind of pharmaceutical composition for treating spinal and joint diseases | |
| CN1175852C (en) | Medicine for treating hyperosteogeny | |
| CN102579581A (en) | Medicine for treating lumbar disc herniation and preparation method thereof | |
| CN103083489B (en) | Traditional Chinese medicine wine for treating lumbar spondylosis, cervical spondylosis, early osteoproliferation and old wounds | |
| CN104107252A (en) | Folium artemisiae argyi powder | |
| CN1899564B (en) | External use medicine for treating hyperosteogeny and protrusion of intervertebral disc |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |